TLSA Short Volume

Tiziana Life Sciences Ltd (TLSA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.1M, listed on NASDAQ, employing roughly 9 people, carrying a beta of 0.42 to the broader market. Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. Led by Ivor R. Elrifi, public since 2018-11-20.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
9.7K
Total Volume
60.1K
Short %
16.10%
30-Day Avg Short %
33.56%

Showing 30 days of FINRA short volume data for Tiziana Life Sciences Ltd.

Learn how short volume is reported and how to read the data →

Frequently asked TLSA short volume questions

What is the daily TLSA short volume?
As of May 15, 2026, Tiziana Life Sciences Ltd (TLSA) short volume is 9.7K shares against 60.1K total reported volume, or 16.10% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is TLSA short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does TLSA short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.